Navigation Links
MedQuist Reports First Quarter 2008 Results
Date:5/12/2008

rtain injunctive relief. The court has been notified of the tentative settlement and the lawsuit has been stayed while the parties continue to negotiate the settlement documentation. The tentative settlement contemplates notice to a settlement class consisting of all medical transcriptionists paid by the line for the period from November 29, 1998 through execution of the settlement agreement and is conditioned on final approval by the court.

Forward-Looking Statements

This report contains forward-looking statement that are based on current expectations, estimates, forecasts and projections about us, the industry in which we operate and other matters, as well as management's beliefs and assumptions and other statements regarding matters that are not historical facts. These statements include, in particular, statements about our plans, strategies and prospects. For example, when we use words such as "projects," "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "should," "would," "could," "will," "opportunity," "potential" or "may," variations of such words or other words that convey uncertainty of future events or outcomes, we are making forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (Securities Act) and Section 21E of the Exchange Act. These statements are only predictions and, as such, are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict, including, without limitation, the risk that a settlement is not ever reached in the consolidated medical transcriptionists' putative class action lawsuit. For a discussion of these risks, uncertainties and assumptions, any of which could cause our actual results to differ from those contained in the forward-looking statement, see the section of MedQuist's Annual Report on Form 10-K for the year ended December 31, 2007, entitled "Risk Factors" and discussions of potential risks a
'/>"/>

SOURCE MedQuist Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. QLT reports initial proof of concept data for punctal plug delivery technology
2. Neurobiological Technologies Reports Third Quarter Financial Results
3. Bionovo Reports First Quarter 2008 Financial Results
4. WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders Meeting
5. Cardium Reports on First Quarter 2008 Highlights and Financial Results
6. Novavax Reports First Quarter 2008 Financial Results
7. Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
8. Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
9. Pharmos Corporation Reports 2008 First Quarter Results
10. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
11. Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... an opportunity to take the lead in two small biot... of Valencia (UV), working together with the IDICH...of the Spanish biotechnology industry. Their concl...more clout than those in English-speaking countrie... has been overlooked by the leading countries in t...
(Date:11/20/2009)...re-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Na... Circuit Court of Appeals reversed a U.S. District...to pursue all of its claims against The Lash Group...trial. CTI filed a complaint against The Lash Gro...ant for CTI,s product TRISENOX, in 2007 seeking $2...
(Date:11/19/2009)...irstCall/ -- Omeros Corporation (Nasdaq: OMER ) t... third quarter ended September 30, 2009. For the t...ted a net loss of $3.9 million, or $1.34 per share....54 per share, for the same period in 2008. For th...y reported a net loss of $15.5 million, or $5.29 p...
(Date:11/19/2009)...Mass., Nov. 19 Arlington Medical R...e leading driver of antibiotic selection in nosoco...y against gram-positive and gram-negative pathogen...nosocomial pneumonia, surveyed European physicians...rovide appropriate coverage against common pathoge...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
...and Technology is soliciting proposals from all te...004 Advanced Technology Program competition. Las...ards being awarded to UW-Madison spin-off compani... 5, 2004 in Chicago, Ill at which the program will...t-industry partnership aids companies in accelerat...
...olina Sen. John Edwards polled well in last weeks ...he North American Free Trade Agreement has been a ... resonated with voters who are eager to blame the ...ans and Mexicans. , ,Lets hope were really not tha...sconsin, not ruining it. , ,Edwards, the son of a ...
... ATM and point-of-sale (POS) processing business, ...network saw its volume increase more than 57% in 2...growth rate of 57% was tremendous and makes ACCEL/...etworks," said Kevin Gregoire, Senior Vice Preside...n 2003, we added more than 22,000 ATMs and 60,000 ...
Other Biology Technology:A Vote Against Free Trade is a Vote Against Wisconsins Long-Term Interests 2
(Date:11/22/2009)... A team of pioneering South Korean scientists hav...ryday plastics through bioengineering, rather than...his groundbreaking research, which may now allow f...stics, is published in two papers in the journal ...nal,s 50th anniversary. , Polymers are molecule...
(Date:11/22/2009)... Scientists at the Brain Research Centre, a partn...ty of Medicine and Vancouver Coastal Health Resear... the mechanism by which brain cells die following ...at damage. The results of the study were recently ...ng a stroke, many brain cells continue to die even...
(Date:11/20/2009)... Using highly precise measurements of plasma lipo...tic resonance spectroscopy (NMR), researchers led ...and Harvard Medical School in Boston, MA, the Fram...S consortium in Stockholm, Sweden and Oxford, Engl...the whole genome among 17,296 women of European an...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2New understanding about mechanism for cell death after stroke leads to possible therapy 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2New arenavirus discovered as cause of hemorrhagic fever outbreak in South Africa and Zambia 47683 1New arenavirus discovered as cause of hemorrhagic fever outbreak in South Africa and Zambia 47683 2New arenavirus discovered as cause of hemorrhagic fever outbreak in South Africa and Zambia 47683 3Governor Rendell Proposes Offering Prescription Help to 30 000 More Older Adults as Part of Plan to Save 2460 Million 47678 1Governor Rendell Proposes Offering Prescription Help to 30 000 More Older Adults as Part of Plan to Save 2460 Million 47678 2Dow AgroSciences World Wide Wheat Agree to Collaborate on Wheat 4520 1Dow AgroSciences World Wide Wheat Agree to Collaborate on Wheat 4520 2
...ffers significant benefits to people with chronic ...sity Technology research. , Dietitian Katrina Cam...red the diets of 62 pre-dialysis patients at the R...ported them with regular contact as part of her th...,s individual situation, a dietitian could interve...
...best to manage some of Florida,s most popular spor... Ault has published Effective Strategies for the M...nagement of the World Tarpon and Bonefish Fisherie... of Marine Biology and Fisheries, conducts an annu... approach to studying tarpon and bonefish, and als...
...care Conference, SUNNYVALE, Calif. and TAMPA, Fla...are setting is a hectic and time consuming,process...tient,s visit.,Fujitsu Computer Products of Americ... products, and HT Systems, a healthcare technology...atientSecure, a,comprehensive patient identificati...
Other Biology News:Diet support helps chronic kidney patients 2New tarpon, bonefish compendium published 2Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management 2Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management 3Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management 4
Human Angiogenesis Antibody Array 2.1 (8) Kit, RayBio from Raybiotech, Inc.
XTT (23-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) from Molecular Probes (Invitrogen)
CryoPlus Square Rack, CP-13-2-CW/100, 27-11/32" OAH from Thermo Scientific
Mouse Anti-Neurogenin-2 Monoclonal Antibody, Unconjugated from R&D Systems
Biology Products: